Regent Peak Wealth Advisors LLC Acadia Pharmaceuticals Inc Transaction History
Regent Peak Wealth Advisors LLC
- $393 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
298Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$691 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$223 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$215 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$188 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$96.8 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.61B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...